Hepatitis Monthly

Published by: Kowsar

Anti-Hepatitis E Antibody in Hemodialysis Patients in Isfahan, Iran: Prevalence and Risk Factors

Seyed Moayed Alavian 1 , Behrooz Ataei 2 , * , Ali Ebrahimi 3 , Omid Pirhaji 3 , Roya Azad 3 , Behrooz Olya 3 and Amir Mohammad Ataei 3
Authors Information
1 Baqiyatallah Research Center for Gastroenterology and Liver Diseases, Baqiyatallah University of Medical Sciences, Tehran, IR Iran
2 Infectious Diseases and Tropical Medicine Research Center, Isfahan University of Medical Sciences, Isfahan, IR Iran
3 Medical Students’ Research Center, Isfahan University of Medical Sciences, Isfahan, IR Iran
Article information
  • Hepatitis Monthly: September 2015, 15 (9); e23633
  • Published Online: September 8, 2015
  • Article Type: Research Article
  • Received: September 14, 2014
  • Revised: February 11, 2015
  • Accepted: March 4, 2015
  • DOI: 10.5812/hepatmon.23633

To Cite: Alavian S M, Ataei B, Ebrahimi A, Pirhaji O, Azad R, et al. Anti-Hepatitis E Antibody in Hemodialysis Patients in Isfahan, Iran: Prevalence and Risk Factors, Hepat Mon. 2015 ;15(9):e23633. doi: 10.5812/hepatmon.23633.

Copyright: Copyright © 2015, Hepatitis Monthly. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited..
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
  • 1. Hosseini-Moghaddam SM, Zarei A, Alavian SM, Mansouri M. Hepatitis E virus infection: a general review with a focus on hemodialysis and kidney transplant patients. Am J Nephrol. 2010; 31(5): 398-407[DOI][PubMed]
  • 2. Dong C, Dai X, Liang J, Dong M, Meng J. Seroprevalence of hepatitis e virus varies considerably among chinese provinces. Hepat Mon. 2012; 12(6): 386-90[DOI][PubMed]
  • 3. Mushahwar IK. Hepatitis E virus: molecular virology, clinical features, diagnosis, transmission, epidemiology, and prevention. J Med Virol. 2008; 80(4): 646-58[DOI][PubMed]
  • 4. Kheradpezhouh M, Taremi M, Gachkar L, Aghabozorgi S, Khoshbaten M. Presence and significance of transfusion-transmitted virus infection in Iranian patients on maintenance hemodialysis. J Microbiol Immunol Infect. 2007; 40(2): 106-11[PubMed]
  • 5. Rodríguez-Frias F, Jardi R, Buti M, Hepatitis E. Molecular virology, epidemiology and pathogenesis. Medicina Clínica. 2012; 138(2, 4): 69-72
  • 6. Zhuang H, Cao XY, Liu CB, Wang GM. Epidemiology of hepatitis E in China. Gastroenterol Jpn. 1991; 26 Suppl 3: 135-8[PubMed]
  • 7. Ataei B, Nokhodian Z, Javadi AA, Kassaian N, Shoaei P, Farajzadegan Z, et al. Hepatitis E virus in Isfahan Province: a population-based study. Int J Infect Dis. 2009; 13(1): 67-71[DOI][PubMed]
  • 8. Assarehzadegan MA, Shakerinejad G, Amini A, Rezaee SA. Seroprevalence of hepatitis E virus in blood donors in Khuzestan Province, southwest Iran. Int J Infect Dis. 2008; 12(4): 387-90[DOI][PubMed]
  • 9. Horl WH. Neutrophil function and infections in uremia. Am J Kidney Dis. 1999; 33(2)[PubMed]
  • 10. Beladi Mousavi SS, Motemednia F, Beladi Mousavi M. Epidemiology of hepatitis e virus infection in patients on chronic hemodialysis. Jundishapur J Microbiol. 2014; 7(5)[DOI][PubMed]
  • 11. Taremi M, Khoshbaten M, Gachkar L, EhsaniArdakani M, Zali M. Hepatitis E virus infection in hemodialysis patients: a seroepidemiological survey in Iran. BMC Infect Dis. 2005; 5: 36[DOI][PubMed]
  • 12. Stefanidis I, Zervou EK, Rizos C, Syrganis C, Patsidis E, Kyriakopoulos G, et al. Hepatitis E virus antibodies in hemodialysis patients: an epidemiological survey in central Greece. Int J Artif Organs. 2004; 27(10): 842-7[PubMed]
  • 13. Pisanti FA, Coppola A, Galli C. Association between hepatitis C and hepatitis E viruses in southern Italy. Lancet. 1994; 344(8924): 746-7[PubMed]
  • 14. Zekavat OR, Makarem A, Karami MY, Amanat A, Mohandes M, Habibagahi M. Serological investigation for hepatitis E virus infection in the patients with chronic maintenance hemodialysis from southwest of Iran. Asian J Transfus Sci. 2013; 7(1): 21-5[DOI][PubMed]
  • 15. Ayoola EA, Want MA, Gadour MO, Al-Hazmi MH, Hamza MK. Hepatitis E virus infection in haemodialysis patients: a case-control study in Saudi Arabia. J Med Virol. 2002; 66(3): 329-34[PubMed]
  • 16. Psichogiou M, Vaindirli E, Tzala E, Voudiclari S, Boletis J, Vosnidis G, et al. Hepatitis E virus (HEV) infection in haemodialysis patients. The Multicentre Haemodialysis Cohort Study on Viral Hepatitis. Nephrol Dial Transplant. 1996; 11(6): 1093-5[PubMed]
  • 17. Kikuchi K, Yoshida T, Kimata N, Sato C, Akiba T. Prevalence of hepatitis E virus infection in regular hemodialysis patients. Ther Apher Dial. 2006; 10(2): 193-7[DOI][PubMed]
  • 18. Ucar E, Cetin M, Kuvandik C, Helvaci MR, Gullu M, Huzmeli C. [Hepatitis E virus seropositivity in hemodialysis patients in Hatay province, Turkey]. Mikrobiyol Bul. 2009; 43(2): 299-302[PubMed]
  • 19. Pourahmad M, Sotoodeh AR, Nasiri N. Hepatitis E virus infection in hemodialysis patients: a seroepidemiological survey in Jahrom, Southern Iran. Hepat Mon. 2009; 9(3): 232-5
  • 20. Thomas DL, Yarbough PO, Vlahov D, Tsarev SA, Nelson KE, Saah AJ, et al. Seroreactivity to hepatitis E virus in areas where the disease is not endemic. J Clin Microbiol. 1997; 35(5): 1244-7[PubMed]
  • 21. Saffar MJ, Farhadi R, Ajami A, Khalilian AR, Babamahmodi F, Saffar H. Seroepidemiology of hepatitis E virus infection in 2-25-year-olds in Sari district, Islamic Republic of Iran. East Mediterr Health J. 2009; 15(1): 136-42[PubMed]
  • 22. Rostamzadeh Khameneh Z, Sepehrvand N, Masudi S. Seroprevalence of hepatitis E among Iranian renal transplant recipients. Hepat Mon. 2011; 11(8): 646-51[PubMed]
  • 23. Haagsma EB, van den Berg AP, Porte RJ, Benne CA, Vennema H, Reimerink JH, et al. Chronic hepatitis E virus infection in liver transplant recipients. Liver Transpl. 2008; 14(4): 547-53[DOI][PubMed]
  • 24. Puoti M, Moioli MC, Travi G, Rossotti R. The burden of liver disease in human immunodeficiency virus-infected patients. Semin Liver Dis. 2012; 32(2): 103-13[DOI][PubMed]
  • 25. Dalton HR, Bendall RP, Keane FE, Tedder RS, Ijaz S. Persistent carriage of hepatitis E virus in patients with HIV infection. N Engl J Med. 2009; 361(10): 1025-7[DOI][PubMed]
  • 26. Ollier L, Tieulie N, Sanderson F, Heudier P, Giordanengo V, Fuzibet JG, et al. Chronic hepatitis after hepatitis E virus infection in a patient with non-Hodgkin lymphoma taking rituximab. Ann Intern Med. 2009; 150(6): 430-1[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader